References

  1. Silber S, Albertsson P, Avilés FF et al. Task Force of Percutaneous Coronary Interventions of the European Society of Cardiology: guidelines for percutaneous coronary interventions. Eur Heart J. 2005; 26(8): 804-847. PubMed | Google Scholar

  2. King SB, Smith SC, Hirshfeld JW Jr et al. Focused Update of the ACC/AHA/SCAI 2005 Guidelines update of Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task force of Practice Guidelines. Circulation. 2008; 117(2): 261-295. PubMed | Google Scholar

  3. Serruys PW, Morice MC, Kappetein P et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. N Engl J Med. 2009; 360(10): 961-972. PubMed | Google Scholar

  4. Tamburino C, Di Salvo ME, Capodanno D et al. Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? insights from a multicentre registry. Eur Heart J. 2009; 30(10): 1171-1179. PubMed | Google Scholar

  5. Migliorini A, Moschi G, Guiarlani L et al. Drug-Eluting Stent Supported Percutaneous Coronary Intervention for Unprotected Left Main Disease. Catheter Cardiovasc Interv. 2006; 68(2): 225-230. PubMed | Google Scholar

  6. Valgimigli M, Malagutti P, Aoki J et al. Sirolimus-Eluting Versus Paclitaxel-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease: a Combined RESEARCH and T-SEARCH Long-Term Analysis. JACC. 2006; 47(3): 507-514. PubMed | Google Scholar

  7. Montalescot G, Brieger D, Eagle KA et al. Unprotected left main revascularization in patients with acute coronary artery syndromes. Eur Heart J. 2009; 30(19): 2308-2317. Google Scholar

  8. Palmerini T, Marzocchi A, Marrozzini C, et al. Comparison Between Coronary Angioplasty and Coronary Baypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna registry). Am J Cardiol. 2006; 98(1): 54-59. PubMed | Google Scholar

  9. Tanigawa J, Sutaria N, Goktekin O, Di Mario C. Treatment of Unprotected Left Main Coronary Artery Stenosis in the Drug-Eluting Stent Era. J Interven Cardiol. 2005; 18(6): 455-465. PubMed | Google Scholar

  10. Black A, Cortina R, Bossi I et al. Unprotected Left Main Coronary Artery Stenting Correlates of Midterm Survival and Impact of Patient Selection. JACC. 2001; 37(3): 832-838. PubMed | Google Scholar

  11. Taggart DP, Kaul S, Boden WE et al. Revascularization of Unprotected Left Main Stem Coronary Artery Stenosis: stenting or surgery. JACC. 2008; 51(9): 885-892. PubMed | Google Scholar

  12. Lee MS, Kapoor N, Jamal F et al. Comparison of Coronary Artery Baypass With Percutaneous Coronary Intervention With Drug-Eluting Stents for Unprotected Left Main Coronary Artery Disease. JACC. 2006; 47(4): 864-870. PubMed | Google Scholar

  13. Chieffo A, Morici N, Maisano F et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery of unprotected left main stenosis: a single center experience. Circulation. 2006; 113(21): 2542-2547. PubMed | Google Scholar

  14. Seung KB, Park DW, YH Kim et al. Stents versus Coronary-Artery Baypass Grafting for Left Main Coronary Artery Disease. N Engl J Med. 2008; 358(17): 1781-1792. PubMed | Google Scholar

  15. Price MJ, Cristea E, Sawhney N et al. Serial angiographic follow-up of Sirolimus-eluting stents for unprotected left main coronary artery revascularisation. J Am Coll Cardiol. 2006; 47(4): 871-877. PubMed | Google Scholar

  16. Valgimigli M, Malagutti P, Rodriguez-Granillo GA et al. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention with drug-eluting stent era: an integrated clinical and angiographic analysis based on the RESEARCH and T-SEARCH registries. J Am Coll Cardiol. 2006; 47(8): 1530-1537. PubMed | Google Scholar

  17. Chieffo A, Park SJ, Valgimigli M et al. Favorable long terme outcome after drug eluting-stent implantation in non-bifurcation lesions that involve unprotected left main coronary artery: a multicenter registry. Circulation. 2007; 116(2): 158-162. PubMed | Google Scholar

  18. Park SJ, Kim YH, Lee BK et al. Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Stenosis Comparison With Bare-Metal Stent Implantation. JACC. 2005; 45(3): 351-356. PubMed | Google Scholar

  19. Morice MC, Serruys PW, Sousa JE et al. Randomized Study with the Sirolimus coated Bx Velocity Balloon-Epandable Stent in the Treatment of the patients with a Novo Native Coronary Artery Lesions: a randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularisation. N Engl J Med. 2002; 346(23): 1773-1780. PubMed | Google Scholar

  20. Moses JW, Leon MB, Popma JJ et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349(14): 1315-1323. PubMed | Google Scholar

  21. Stone GW, Ellis SG, Cox DA et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004, 350(3): 221-231. PubMed | Google Scholar

  22. Valgimigli M, Mieghem CA, Ong AT et al. Short and long term clinical outcome after drug eluting-stent implantation for percutaneous treatment of left main coronary artery disease: insights from the rapamycin-eluting stent and taxus stent evaluated at Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation. 2005; 111(11): 1383-1389. PubMed | Google Scholar